A process for the preparation of polymorphic form of robenacoxib
EP3669866A1
Pharmaceutical composition comprising apixaban
EP3666773A1
Process for preparing apixaban
EP3595441A1
Stable topical veterinary composition
EP3505158A1
Pharmaceutical composition of lenalidomide pharmaceutically acceptable acid addition salt
EP3466923A1
Process for the preparation of agomelatine in crystalline form
EP3466413A1
Pharmaceutical composition containing agomelatine and process for the preparation thereof
WO2017167949A1
Crystalline forms of bilastine
EP3407874A1
Fast dispersible pharmaceutical composition comprising tyrosine-kinase inhibitor
EP3236950A1
Pharmaceutical composition comprising candesartan or pharmaceutically acceptable salts or esters thereof and amlodipine or pharmaceutically acceptable salts thereof
EP3236952A1
Pharmaceutical tablet composition
WO2016016431A1
Pharmaceutical formulation comprising an opioid agonist and an opioid antagonist prepared by melt granulation using lipid esters
EP3466951A1
A process for the preparation of cgmp-phosphodiesterase inhibitor and oral pharmaceutical formulation comprising tadalafil co-precipitates
EA032126B1
Solid pharmaceutical composition comprising metformin and vildagliptin and process for manufacturing same
WO2015086768A1
Pharmaceutical composition comprising a pharmaceutically acceptable salt of rasagiline
